Your browser doesn't support javascript.
loading
Forty-eight-week evaluation of lopinavir/ritonavir, a new protease inhibitor, in human immunodeficiency virus-infected children.
Pediatr Infect Dis J ; 22(3): 216-24, 2003 Mar.
Article de En | MEDLINE | ID: mdl-12634581
Recherche sur Google
Collection: 01-internacional Base de données: MEDLINE Sujet principal: Pyrimidinones / Infections à VIH / Inhibiteurs de la transcriptase inverse / Ritonavir / Dose maximale tolérée Type d'étude: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Child / Child, preschool / Female / Humans / Infant / Male Langue: En Journal: Pediatr Infect Dis J Sujet du journal: DOENCAS TRANSMISSIVEIS / PEDIATRIA Année: 2003 Type de document: Article Pays d'affiliation: Panama
Recherche sur Google
Collection: 01-internacional Base de données: MEDLINE Sujet principal: Pyrimidinones / Infections à VIH / Inhibiteurs de la transcriptase inverse / Ritonavir / Dose maximale tolérée Type d'étude: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Child / Child, preschool / Female / Humans / Infant / Male Langue: En Journal: Pediatr Infect Dis J Sujet du journal: DOENCAS TRANSMISSIVEIS / PEDIATRIA Année: 2003 Type de document: Article Pays d'affiliation: Panama